Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5-aminolevulinic acid on malignant skin tumors during Mohs surgery

Intraoperative use of spectroscopic detection of protoporphyrin IX from oral 5-aminolevulinic acid on malignant skin tumors during Mohs surgery - Intraoperative use of 5-aminolevulinic acid on malignant skin tumors during Mohs surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017234

Enrollment

Registered

2015-04-22

Start date

2010-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)

Interventions

Administration of 5-aminolevulinic acid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with malignant skin tumors

Exclusion criteria

Exclusion criteria: the patient with porphilia

Design outcomes

Primary

Measure	Time frame
a resection method using 5-ALA-mediated PDD as a treatment to completely remove malignant skin tumors	—

Countries

Japan

Contacts

Public ContactSatoru Aoyagi

Hokkaido University Graduate School of Medicine Department of Dermatology

s.aoyagi@aoyagi-derm.jp011-706-7387

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026